Nano Nuclear Energy Inc.
NNENano Nuclear Energy is an American company focused on the development of nuclear microreactor technologies and related nuclear services, headquartered in New York City and Oak Ridge, Tennessee. The company is an official member of the United States Nuclear Industry Council (USNIC) and the Nuclear Institute based in the United Kingdom. It was selected as a founding member of the HALEU (High Assay Low Enriched Uranium) consortium of the United States Department of Energy.
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Aug 13, 2026
5wMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
How NNE's past catalysts played out
No drugs found in this phase.
Full breakdown — the signals behind the verdict
Frequently asked questions
When is Nano Nuclear Energy Inc.'s next FDA catalyst?→
Nano Nuclear Energy Inc.'s (NNE) next tracked catalyst is a Earnings expected August 13, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track NNE biotech catalysts?→
Add NNE to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Nano Nuclear Energy Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.